China Usa Brazil city Delhi vaccine China Usa Brazil city Delhi

Chinese Sinovac covid vaccine more than 50% effective, but data withheld

Reading now: 615
www.livemint.com

Sinovac Biotech Ltd. was found to be more than 50% effective in a Brazilian clinical trial, though researchers delayed releasing more information at the request of the company.A 50% efficacy rate is a minimum standard set by US regulators for emergency authorization of Covid vaccines.

Messenger RNA vaccines from Moderna Inc. and Pfizer Inc. have produced far better results, reducing symptomatic Covid cases by well over 90% in giant trials.Also Read | Inside the farmer disquiet at Delhi’s doorstepChinese vaccine developers have been slow compared with their western peers in releasing efficacy data on their shots.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Gojira reschedule UK and European tour due to COVID-19 - nme.com - Switzerland - Germany - Britain - Ireland - France - city Berlin - Netherlands - Denmark - city Dublin - county Hall - county Forest - city Budapest - Belgium - city Prague - city Milan - city Stockholm - city Oslo - county Lyon - city Helsinki - city Copenhagen - city Luxembourg
nme.com
95%
994
Gojira reschedule UK and European tour due to COVID-19
Gojira have rescheduled their upcoming UK and European tour due to COVID-19 restrictions.The French metal titans were supposed to hit the road last month, beginning in Helsinki, with stop-offs in Oslo, Stockholm, Copenhagen, Berlin, Prague, Budapest and other cities throughout January into February and March.However, they’ve announced that they will now kick off their European tour on July 5 in Brussels and conclude it in Milan on July 31 at Carroponte.The UK and Ireland leg of the tour, meanwhile, has moved to 2023 and will begin on February 11 in Dublin and conclude at London’s Alexandra Palace on February 22.Gojira will then play rescheduled shows in Bordeaux, Paris, Luxembourg and Lyon between February 24 and 28, 2023.“We cannot express how much we appreciate your continued patience and support while we worked through last month’s postponement,” the band said in a social media post.“Despite our best efforts to resume touring this month, the continued uncertainty in various territories has left us with no other choice but to reschedule the remaining dates of the tour as well.“In light of this unfortunate news we are pleased to share the rescheduled dates for the entire European Tour below.”A post shared by Gojira Official (@gojiraofficial)Original tickets for the tour – which sees support from special guests Alien Weaponry and Employed To Serve – remain valid.
New projections indicate number of COVID-19 patients in Quebec will continue to drop - globalnews.ca - county Gaston
globalnews.ca
86%
713
New projections indicate number of COVID-19 patients in Quebec will continue to drop
COVID-19 hospitalizations in Quebec is expected to continue to decline over the next two weeks, a government health-care research institute projected Wednesday.By the end of the month, the number of people in Quebec hospitals with COVID-19 should drop by about 500, to 1,500 patients, according to the Institut national d’excellence en santé et services sociaux. There should be about half the number of intensive care patients by that time, or about 60, it added.“For all of Quebec, the projections suggest a slight decrease in new hospitalizations,” INESSS said in a news release, adding that it expected the number of new hospitalizations to reach around 90 per day within the next two weeks.The research institute said its projections should be interpreted with caution as it cannot forecast the effect of changes to COVID-19 restrictions. Quebec reopened gyms and spas on Monday, shortly after lifting restrictions on private gatherings and limits on the number of people who can dine together at restaurants.A separate health-care research institute said Wednesday that preliminary results from a vaccine study indicate three doses of COVID-19 vaccine offer more protection compared with two doses against severe and mild forms of the disease caused by the Omicron variant.“The effectiveness is highest against serious COVID-19 infections — those that lead to hospitalizations,” the Institut national de santé publique du Quebec said in a news release.
DMCA